Search Within

Karen Anne Cadoo

Formats
  1. Meeting Abstract (58)
  2. Journal Article (54)
  3. Book Section (1)
Groups
  1. Department of Medicine (113)
  2. Gynecologic Medicine Service (113)
  3. Solid Tumor Oncology Division (113)
  4. Survivorship Research (77)
  5. Gynecology Disease Management Team (76)
  6. GDMT, Medicine (63)

More Groups

People
  1. Carol Aghajanian (48)
  2. Nadeem Abu-Rustum (34)
  3. Mark Robson (33)
  4. Kenneth Offit (32)
  5. Diana Mandelker (31)
  6. Zsofia Stadler (30)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (7)
  5. 2021 (15)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Gynecologic Oncology (15)
  3. Cancer Research (8)
  4. International Journal of Gynecological Cancer (8)
  5. Clinical Cancer Research (6)
  6. JCO Precision Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. Elsevier Inc. (21)
  3. American Association for Cancer Research (15)
  4. Nature Publishing Group (11)
  5. Lippincott Williams & Wilkins (8)
  6. Nature Research (7)

More Publishers

Results (113)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers
    Meeting Abstract

    Cowan, R.; Pedra Nobre, S.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Gardner, G.; Abu-Rustum, N.; Aghajanian, C.; Cadoo, K.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma
    Meeting Abstract

    Basaran, D.; Bruce, S.; Aviki, E.; Mueller, J.; Broach, V.; Cadoo, K.; Soslow, R.; Alektiar, K.; Abu-Rustum, N.; Leitao, M.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Genomic profiling of recurrent "ultra-low risk" endometrial cancer
    Meeting Abstract

    Stasenko, M.; Feit, N.; Lee, S.; Selenica, P.; Soslow, R. A.; Cadoo, K. A.; Alektiar, K.; Leitao, M. M. Jr; Gardner, G.; Abu-Rustum, N. R.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Toward automation of germline variant curation in clinical cancer genetics
    Journal Article

    Ravichandran, V.; Shameer, Z.; Kemel, Y.; Walsh, M.; Cadoo, K.; Lipkin, S.; Mandelker, D.; Zhang, L.; Stadler, Z.; Robson, M.; more...
    Genetics in Medicine (2019)

    Fulltext@MSK | Save
  • The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
    Journal Article

    Figlioli, G.; Bogliolo, M.; Catucci, I.; Caleca, L.; Lasheras, S. V.; Pujol, R.; Kiiski, J. I.; Muranen, T. A.; Barnes, D. R.; Dennis, J.; more...
    npj Breast Cancer (2019)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study
    Meeting Abstract

    Moore, K. N.; Chambers, S. K.; Hamilton, E. P.; Chen, L. M.; Oza, A. M.; Ghamande, S. A.; Konecny, G. E.; Plaxe, S. C.; Spitz, D. L.; Geenen, J. J. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Boland, J. L.; Cadoo, K. A.; Friedman, C. F.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC)
    Meeting Abstract

    Cadoo, K. A.; Meyers, M. L.; Burger, R. A.; Armstrong, D. K.; Penson, R. T.; Gordon, M. S.; Fleming, G. F.; Moroney, J. W.; Hamilton, E. P.; Duska, L. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations
    Meeting Abstract

    Carlo, M. I.; Kemel, Y.; Breen, K.; Cadoo, K. A.; Walsh, M. F.; Abida, W.; Autio, K. A.; Danila, D. C.; Kampel, L. J.; Morris, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save